美国首例人体基因治疗获批。

Diskussionsforum medizinische Ethik Pub Date : 1990-09-01

J G Meran

{"title":"美国首例人体基因治疗获批。","authors":"J G Meran","doi":"","DOIUrl":null,"url":null,"abstract":"The clinical protocol to treat infants with severe combined immuno deficiency due to adenosine deaminase (ADA) deficiency by means of gene thereapy has been approved recently. The Human Gene Therapy Subcommittee and the Recombinant DNA Advisory Committee (RAC) of the National Institutes of Health (NIH) concluded the review on July 30th and opened the door for the first federally approved somatic Human Gene Therapy.","PeriodicalId":77110,"journal":{"name":"Diskussionsforum medizinische Ethik","volume":" 3","pages":"2 p. following 428"},"PeriodicalIF":0.0000,"publicationDate":"1990-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[First somatic human gene therapy in the USA approved].\",\"authors\":\"J G Meran\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The clinical protocol to treat infants with severe combined immuno deficiency due to adenosine deaminase (ADA) deficiency by means of gene thereapy has been approved recently. The Human Gene Therapy Subcommittee and the Recombinant DNA Advisory Committee (RAC) of the National Institutes of Health (NIH) concluded the review on July 30th and opened the door for the first federally approved somatic Human Gene Therapy.\",\"PeriodicalId\":77110,\"journal\":{\"name\":\"Diskussionsforum medizinische Ethik\",\"volume\":\" 3\",\"pages\":\"2 p. following 428\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diskussionsforum medizinische Ethik\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diskussionsforum medizinische Ethik","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

近年来，通过基因疗法治疗婴儿因腺苷脱氨酶(ADA)缺乏引起的严重联合免疫缺陷的临床方案已获得批准。美国国立卫生研究院(NIH)人类基因治疗小组委员会和重组DNA咨询委员会(RAC)于7月30日结束了审查，并为第一个获得联邦政府批准的体细胞人类基因治疗打开了大门。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

[First somatic human gene therapy in the USA approved].

The clinical protocol to treat infants with severe combined immuno deficiency due to adenosine deaminase (ADA) deficiency by means of gene thereapy has been approved recently. The Human Gene Therapy Subcommittee and the Recombinant DNA Advisory Committee (RAC) of the National Institutes of Health (NIH) concluded the review on July 30th and opened the door for the first federally approved somatic Human Gene Therapy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Diskussionsforum medizinische Ethik

自引率

0.00%

发文量

期刊最新文献

[Brief definitions of concepts in medical ethics. 33. Assisted suicide--the problem of the "double effect"]. [Restriction of ethics in medicine]. [Somatic gene therapy--aspects from theological discussion]. [The human embryo as a teleologically defined entity]. [Bioethics in Hong Kong--between morals and economics].